choriocarcinoma(redirected from malignant trophoblastic tumour)
Also found in: Dictionary, Encyclopedia.
A choriocarcinoma is type of cancer germ cell containing trophoblast cells.
Choriocarcinomas are cancers that develop from germ cells, cells that ordinarily turn into sperm or eggs. Choriocarcinomas resemble the cells that surround an embryo in the uterus. Most of these cancers form inside the reproductive organs. Some originate in the testes or ovaries, especially in young adults. Others develop in the uterus after a pregnancy or miscarriage—particularly often after a mole. A few choriocarcinomas arise in sites outside the reproductive organs. Such "extragonadal" tumors are usually found in young adults and are more common in males.
Choriocarcinomas are one of the most dangerous germ cell cancers. Choriocarcinomas usually grow quickly and spread widely. Occasionally, this cancer grows so fast that the original tumor outgrows its blood supply and dies, leaving behind only a small scar.
Causes and symptoms
Choriocarcinomas result from genetic damage to a germ cell. Males with Klinefelter syndrome are especially likely to develop extragonadal germ cell tumors.
The symptoms of a choriocarcinoma vary, depending on where the tumor originates and where it spreads. In the uterus, the most common symptom is bleeding. Cancers in the ovary often have only subtle signs such as widening of the waistline or pain. In the testes, choriocarcinomas can often be felt as small painless lumps. Choriocarcinomas that spread to other organs may reveal their presence by bleeding. In the brain, this bleeding can cause a stroke.
Choriocarcinomas are usually referred to an oncologist, a doctor who specializes in cancer treatment. To diagnose this tumor, the doctor will do a physical examination and examine the internal organs with x rays or ultrasound studies. Choriocarcinomas are not always biopsied before being treated, because they tend to bleed heavily. Spreading of the cancer is detected with x rays, ultrasound studies, computed tomography (CT), or magnetic resonance imaging (MRI) scans.
Most choriocarcinomas make human chorionic gonadotropin (hCG), a hormone normally found only during pregnancy. The presence of hCG in the blood can help diagnose this cancer and monitor the success of treatment.
Choriocarcinomas are usually treated by surgical removal of the tumor and chemotherapy. Radiation is occasionally used, particularly for tumors in the brain.
Complementary treatments can decrease stress, reduce the side effects of cancer treatment, and help patients feel more in control. For instance, some people find activities such as yoga, massage, music therapy, meditation, prayer, or mild physical exercise helpful.
The prognosis for choriocarcinomas in the uterus is very good. Although these tumors have often spread throughout the body, chemotherapy results in a cure or remission in at least 80-90% of cases. Women who have had choriocarcinomas often go on to have normal pregnancies and deliveries.
Choriocarcinomas in other sites have a poorer prognosis. These tumors tend to spread quickly and don't always respond well to chemotherapy. Although treatment can be effective, the outcome usually depends on how widely the cancer is dispersed. Generally, the prognosis is worse if the cancer can be found in the liver or brain, if hCG levels are high, or if the original tumor developed outside the gonads. Five-year survival with testicular cancers can range from 92% for tumors that have spread only to the lungs to 48% to tumors that have spread to other internal organs.
There is no known means of prevention. However, early detection of the symptoms and prompt medical treatment can improve the odds of survival.
Biopsy — A sample of an organ taken to look for abnormalities. Also, the technique used to take such samples.
Chemotherapy — The treatment of cancer with drugs.
Computed tomography (CT) — A special x ray technique that produces a cross sectional image of the organs inside the body.
Extragonadal — In a location other than the reproductive organs.
Germ cell — One of the cells that ordinarily develop into eggs or sperm (also sperm and eggs).
Gonads — The ovaries or testes.
Klinefelter syndrome — A condition caused by extra X chromosome(s) in a male, that results in small testes and infertility together with increased height, decreased facial hair, and sometimes breast enlargement.
Magnetic resonance imaging — A type of study that uses changes induced by magnets to see cells and tissues inside the body.
Mole — A mass of abnormal, partially developed tissues inside the uterus (womb). Moles develop during a pregnancy that begins with an abnormal fertilization.
Ovaries — The female sex organs that make eggs and female hormones.
Remission — The disappearance of the symptoms of cancer, although all of the cancer cells may not be gone.
Reproductive organs — The group of organs (including the testes, ovaries, and uterus) whose purpose is to produce a new individual and continue the species.
Testes — The male sex organs that make sperm and male hormones.
Testicular cancer — A cancer that originates in the testes.
Trophoblast — The tissues that surround an embryo and attach it to the uterus.
Tumor — A lump made up of abnormal cells.
Uterus — The organ where a child develops (womb).
Baker, Vicki V. "Gestational Trophoblastic Disease." In Clinical Oncology, edited by Martin D. Abeloff, et al., 2nd ed. Philadelphia: Churchhill Livingstone, 2000.
Cotran, Ramzi S., Vinay Kumar, and Tucker Collins, editors. "The Male Genital Tract." In Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: W.B. Saunders, 1999.
Crum, Christopher P. "The Female Genital Tract." In Robbins Pathologic Basis of Disease, edited by Ramzi S. Cotran, Vinay Kumar, and Tucker Collins, 6th ed. Philadelphia: W.B. Saunders, 1999.
Small, Eric J., and Frank M. Torti. "The Testes." In Clinical Oncology, edited by Martin D. Abeloff, et al., 2nd ed. Philadelphia: Churchhill Livingstone, 2000.
Smithson, William A. "Gonadal and Germ Cell Neoplasms." In Nelson Textbook of Pediatrics, edited by Richard E. Behrman, et al., 16th ed. Philadelphia: W.B. Saunders, 2000.
Thigpen, James Tate. "Ovaries and Fallopian Tubes." In Clinical Oncology, edited by Martin D. Abeloff, et al., 2nd ed. Philadelphia: Churchill Livingstone, 2000.
Newlands, Edward S., Fernando J. Paradinas, and Rosemary A. Fisher. "Current Therapeutic Issues in Gynecologic Cancer. Recent Advances in Gestational Trophoblastic Disease." Hematology/Oncology Clinics of North America 13, no. 1 (February 1999): 225-44.
"Chemotherapy and You: A Guide to Self-help During Cancer Treatment." CancerNet. June 1999. [cited April 5, 2001]. http://cancernet.nci.nih.gov/peb/chemo_you/index.htm.
"Extragonadal Germ Cell Tumors." CancerNet. http://cancernet.nci.nih.gov/pdq.html.
"Ovarian Germ Cell Tumor." CancerNet. Feb. 2001. [cited April 27, 2001]. http://cancernet.nci.nih.gov/pdq.html.
a malignant neoplasm of trophoblastic cells formed by abnormal proliferation of the placental epithelium, without production of chorionic villi. It is a malignant variant of gestational thromboplastic disease and can occur following a full term pregnancy, pregnancy complicated by a mole, ectopic pregnancy, or abortion.
A highly malignant neoplasm derived from placental syncytial trophoblasts and cytotrophoblasts that forms irregular sheets and cords, which are surrounded by irregular "lakes" of blood; villi are not formed; neoplastic cells invade blood vessels. Hemorrhagic metastases develop relatively early in the course of the illness, and are frequently found in the lungs, liver, brain, and vagina, and various other pelvic organs; choriocarcinoma may follow any type of pregnancy, especially hydatidiform mole, and occasionally originates in teratoid neoplasms of the ovaries or testes.
n. pl. choriocarcino·mas or choriocarcino·mata (-mə-tə)
A malignant tumor that develops from trophoblast cells and usually occurs in the uterus.
An aggressive, rapidly growing malignancy arising from trophoblastic tissue, either in a hydatidiform mole or de novo.
More common in Asian women; average age, 31.
Vaginal bleeding; with metastases to the lungs: haemoptysis, chest pain, shortness of breath.
Multiple infiltrates of various size and shape.
Marked increase in beta-hCG.
Methoterexate for early disease, EMACO (etoposide, methotrexate, actinomycin D, cyclosphosphamide, vincristine (oncovin)) for intermediate to advanced disease.
Generally excellent; up to 95% cure rate, even for cases with metastases.
Cause of death
Haemorrhage, pulmonary insufficiency, drug toxicity, sepsis, renal failure.
Mediastinal choriocarcinomas are more common in young males, often associated with elevated hCG; they may cause gynaecomastia and impotence, and have a dismal prognosis.
choriocarcinomaChorioblastoma, chorioepithelioma, gestational choriocarcinoma, malignant mole An aggressive rapidly growing malignancy arising from the placental trophoblast, which may arise in a hydatidiform mole, or de novo Epidemiology Most common in Asian ♀, predominantly in ♂ with a peak incidence Clinical Continued vaginal bleeding in ♀ with a recent hydatidiform mole, abortion or term pregnancy Management MTX Cause of death Hemorrhage, pulmonary insufficiency, drug toxicity, sepsis, renal failure
A highly malignant neoplasm derived from placental syncytial trophoblasts and cytotrophoblasts; villi are not formed; neoplastic cells invade blood vessels. Hemorrhagic metastases are found in the lungs, liver, brain, and vagina; choriocarcinoma may follow any type of pregnancy, especially one involving hydatidiform mole, and occasionally originates in teratoid neoplasms of the ovaries or testes.